articleThe LancetJul 1, 2002Closed access

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial

FFFerenc FolláthJCJGF ClelandHJH. Just JPJGY Papp HSHasso Scholz

University Hospital of Zurich · University of Hull · +8 more institutions

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,178

total citations

FWCI: 40.90
Percentile: 100%
References: 32

Citations per year

Authors

11

FF
Ferenc FolláthCorresponding
University Hospital of Zurich
JC
JGF Cleland
University of Hull
HJ
H. Just
University of Freiburg
JP
JGY Papp
University of Szeged
HS
Hasso Scholz
Eppendorf (Germany)

Topics & keywords

Topics

Keywords

Levosimendan
Dobutamine
Medicine
Hemodynamics
Pulmonary wedge pressure
Anesthesia
Clinical endpoint
Heart failure

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.